Understanding your genetic peptide predispositions helps optimize whether semaglutide injection, oral formulations, or dual-compound protocols align best with your metabolism
Anyone with significant medical conditions, anyone pregnant or breastfeeding, and anyone on multiple medications needs a careful review first not because problems are expected, but because limited human data means we don't assume
Allodynia produces sharp, burning, or stinging sensations specifically triggered by touch or temperature
The European Medicines Agency (EMA) recently launched an investigation into Novo Nordisk's GLP-1 treatments, including Saxenda (ingredient: liraglutide), Ozempic (ingredient: semaglutide), and Wegovy (ingredient: semaglutide), after the Icelandic Medicines Agency reported two adverse events of suicidal or self-harming behavior in patients taking Saxenda and Ozempic
Dispose of the Old Vial: Do not use the remaining medication just in case
Provides targeted support for iron-deficiency anemia*